PA-BOOMI
Boomi™, the intelligent integration and automation leader, today announced an enhanced version of Boomi for SAP to help accelerate the migration of SAP Business Warehouse (SAP BW) customers to SAP Datasphere. By leveraging Amazon Web Services (AWS), Boomi aims to address the critical challenge of enterprise customers who need to transition to SAP Datasphere, and unlock the full potential of their business data in a cost-effective and streamlined way.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240509748233/en/
Boomi to Simplify and Accelerate the Move to SAP Datasphere (Graphic: Business Wire)
Addressing a Critical Challenge in Data Migration
With mainstream support ending for SAP BW coming at the close of 2027, SAP BW customers are encouraged to migrate to SAP Datasphere, which will enable business transformation by delivering seamless, scalable access to business-critical data. However, the move to SAP Datasphere requires significant investment and substantial effort from highly-skilled individuals.
Boomi for SAP accelerates the transition to SAP Datasphere on AWS through Boomi’s low-code, integration platform. Customers can simply log into the Boomi Enterprise Platform and leverage a pre-built accelerator specifically designed to speed the migration and integration of data into SAP Datasphere on AWS.
“SAP Datasphere is SAP's foundation for a business data fabric, but many companies with earlier versions of SAP BW are overburdened with the cost-prohibitive, time-consuming, and resource-intensive process of migrating to it,” said Steve Lucas, CEO at Boomi. “This new collaboration leverages Boomi’s expertise in intelligent integration and automation, along with AWS services, to provide a lighter, faster, more cost-effective way for organizations to transition to SAP Datasphere, getting the most out of their SAP investments and their data.”
Key benefits of Boomi for SAP include:
- Avoid costly SAP BW version upgrades and the need for a staging area, resulting in time and cost savings
- The ability to select which SAP BW Queries and BW InfoProviders to move to Datasphere
- Efficient data tiering to SAP Datasphere and Amazon Redshift, a fully managed, petabyte-scale data warehouse service, enabling businesses to move less frequently used data to more affordable cloud storage tiers
- Faster integration of third-party data into SAP Datasphere at a lower cost
- Better data preparation for more efficient use of data analytics and artificial intelligence (AI)
- A smooth procurement process in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on AWS
“The ability to aggregate diverse datasets is emerging as a critical advantage as organizations recognize the pivotal role of AI in their operations,” said Matt Aslett, director of research at Ventana Research, part of ISG. “Data preparation and integration is imperative to ensuring more efficient utilization of data analytics and AI, and the acceleration of business outcomes through data-driven decision-making.”
“Working with AWS reinforces Boomi’s commitment to delivering a practical path to enterprise analytics and AI, beginning with a robust data foundation,” said Ed Macosky, Chief Product and Technology Officer at Boomi. “With the Boomi Enterprise Platform, organizations can achieve a more flexible, scalable, and connected ecosystem to drive innovation, future-proof their IT investments, reduce total cost of ownership, and enhance business outcomes.”
Availability
Boomi for SAP is available in AWS Marketplace, and on the Boomi Enterprise Platform.
Additional Resources
- Find Boomi in AWS Marketplace
- Explore Boomi Recipes and Accelerators for SAP in the Discover Catalog
- Explore the Boomiverse Community
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240509748233/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Original “Titanic Cherub” From James Cameron’s Epic Film Heads to Auction December 9 & 1024.11.2025 21:48:00 CET | Press release
Iconic Hollywood Artifact Indelibly Linked with “Jack & Rose” Portrayed by Kate Winslet and Leonardo DiCaprio One of the most recognizable and beloved set pieces from James Cameron’s Titanic heads to auction on December 9 &10 —the original Grand Staircase Cherub, seen in multiple scenes of the 1997 blockbuster, including the pivotal moment when Jack and Rose meet in front of the First Class Dining Room and the climactic moment when the Atlantic Ocean bursts through the skylight and floods the staircase, and cherub. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124056883/en/ The iconic “cherub” with Leonardo DiCaprio & Kate Winslet in James Cameron’s “TITANIC”. The ornate fixture—crafted for the full-scale recreation of Titanic’s Grand Staircase—was gifted by the production to Martin Biallas, CEO of SEE Global Entertainment, whose immersive exhibitions have brought the world’s most famous ship to millions of fans. It now
Access Advance Announces Major Growth in Its HEVC and VVC Patent Pools24.11.2025 16:10:00 CET | Press release
Access Advance LLC today announced significant expansions of both its HEVC Advance and VVC Advance Patent Pools during the second and third quarters of 2025, underscoring continued industry confidence in the company's balanced and transparent approach to video codec licensing. This growth follows the successful January 2025 launch of Access Advance's Video Distribution Patent ("VDP") Pool, demonstrating the company's expanding role in comprehensive video codec patent licensing solutions. Among the many highlights, Sharp Corporation joined the HEVC Advance Patent Pool as a Licensor, bringing valuable intellectual property assets to the pool's already extensive patent portfolio. Additionally, Huawei Technologies Co., Ltd., already an HEVC Advance Licensor and Licensee, expanded its collaboration with Access Advance by joining the VVC Advance Patent Pool as a Licensee. HP Inc. also expanded its license to include the VVC Advance Patent Pool after previously joining HEVC Advance in 2024, w
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland24.11.2025 15:05:00 CET | Press release
Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124545344/en/ The agreement represents Microsize’s second acquisition from Lonza, following the successful 2022 divestment of its Quakertown, Pennsylvania site. In this transaction, Schedio Group – a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services – is investing alongside Microsize to strengthen and localize its operational base in Europe, advancing a shared vision to lead the next generation of integrated particle engineering solutions. With more than 30 years of experience, Mic Mac has served the pharmaceutical industry with proven GMP-compliant jet milling and micronization capabilities for b
Hytera to Debut S1 E at PMRExpo 202524.11.2025 14:17:00 CET | Press release
Hytera, a leading global provider of critical communications technologies and solutions, today introduced the S1 E, a business-ready, palm-sized two-way radio designed specifically for the retail sector, expanding the portfolio of S Series and providing one more option for retail users to choose for their daily operations. The S1 E will make its debut at PMRExpo, the Europe's premier trade fair for secure, mission- and business-critical communication, taking place from November 25th to 27th, 2025, at Koelnmesse in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124768341/en/ Hytera New Released Licence-free Analogue Business Radio S1 E Adhering to the S Series’ signature design language, the S1 E combines a stylish, modern, and minimalist aesthetic with practical functionality. Weighing under 85g, the S1 E provides all-day wearing comfort without tugging or weighing down uniforms. Key enhancements and sta
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis24.11.2025 14:00:00 CET | Press release
Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia GravisCladribine capsules has received Fast Track designation and Orphan Drug Designation by the US FDAMerck has established an MG patient council to provide insights on how to best meet the needs of patients in the gMG rare disease community Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis (gMG). In June 2023, the FDA granted Orphan Drug Designation for cladribine capsules for the treatment of gMG. In addition, the Company is actively collaborating with patient organizations and Ad Scientiam, a medical technology company, to support a patient-directed approach to the future management of gMG. If approved
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom